US$ 25.34
first glp-1 Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Emerging Trends in the Development
Description
326 , E528E536 (2024)

Prior authorization through your Part D plan is required

Berard L, Bonnemaire M, Mical M, Edelman S

These arise because GLP1 agonists slow stomach emptying and intensify satiety signals, which can leave you feeling uncomfortably full after small meals and trigger food aversions
